StockNews.AI

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026

StockNews.AI • 2 days

HAE
High Materiality8/10

Information

BOSTON, Jan. 7, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that the Company intends to publish third quarter fiscal year 2026 financial results at 6:00 am ET on Thursday, February 5, 2026. The

Original source

AI Summary

Haemonetics Corporation plans to publish its third quarter fiscal results on February 5, 2026, accompanied by a conference call for investors. This financial update is critical for stakeholders and could influence the stock's trajectory significantly.

Trading Thesis

Investors should closely monitor HAE's Q3 results for potential trading opportunities.

Market-Moving

  • Upcoming earnings report could lead to significant stock volatility.
  • Market reaction expected based on earnings performance.
  • Investors are advised to prepare for possible trading strategies before earnings.
  • Conference call may impact investor sentiment regarding future guidance.
  • Stock price may shift significantly based on earnings surprise.

Key Facts

  • Q3 2026 results announcement set for February 5, 2026.
  • Conference call will take place at 8:00 AM ET on the same day.
  • Live webcast available on investor relations website.
  • Replay of the call will be accessible for one year.

Companies Mentioned

  • Haemonetics Corporation (HAE): Financial performance may indicate future growth prospects.

Earnings

This update falls under earnings reporting, a crucial factor for evaluating company performance and stock price movements. Investors often closely watch earnings calls for insights into future guidance and strategic direction.

FAQ

Why Bullish?

Positive earnings surprises often result in stock price increases, as seen historically. If Haemonetics meets or exceeds expectations, it could bolster investor confidence.

How important is it?

The article provides important information about Haemonetics’ financial results, which can directly influence the stock price leading to heightened investor interest.

Why Short Term?

The immediate effects of earnings releases typically drive short-term stock volatility. Historical data indicates price movements often occur during earnings season.

Related Companies

BOSTON, Jan. 7, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that the Company intends to publish third quarter fiscal year 2026 financial results at 6:00 am ET on Thursday, February 5, 2026. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on February 5, 2026.

The call can be accessed via teleconference at: Q3 2026 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.

A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/uz42wd2z 

A replay of the conference call and webcast will be available for one year beginning on February 5, 2026 at 11:00 am ET using the conference call webcast link provided in this press release.

ABOUT HAEMONETICS

Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:



Olga Guyette, Vice President-Investor Relations & Treasury

David Trenk, Manager-Investor Relations

(781) 356-9763

(203) 733-4987

olga.guyette@haemonetics.com

david.trenk@haemonetics.com

Media Contact:



Josh Gitelson, Sr. Director-Global Communications



(781) 356-9776



josh.gitelson@haemonetics.com 



Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-third-quarter-fiscal-year-2026-results-february-5-2026-302655773.html

SOURCE Haemonetics Corporation

Related News